Evidence map›Paper›PMID 37400715›Full record

ArticleNature biomedical engineering2023

Simultaneous quantitative imaging of two PET radiotracers via the detection of positron-electron annihilation and prompt gamma emissions.

Edwin C Pratt, Alejandro Lopez-Montes, Alessia Volpe, Michael J Crowley, Lukas M Carter, Vivek Mittal, Nagavarakishore Pillarsetty, Vladimir Ponomarev, Jose M Udías, Jan Grimm and 1 more

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Image quality and lesion detectability in simulated [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Separation of simultaneously acquired [European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Article
  7. Review
  8. Radiolabeling lipoproteins to study and manage disease.European journal of nuclear medicine and molecular imaging · 2025
    Review
  9. Article
  10. Multiplexed imaging of radionuclides.Nature biomedical engineering · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Edwin C PrattDepartment of Pharmacology, Weill Cornell Graduate School, New York, NY, USA.ORCID 0000-0002-6054-6983
Alejandro Lopez-MontesNuclear Physics Group, EMFTEL and IPARCOS, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0002-3307-532X
Alessia VolpeDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-3087-9178
Michael J CrowleyDepartment of Cell and Developmental Biology, Weill Cornell Graduate School, New York, NY, USA.
Lukas M CarterDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4848-4190
Vivek MittalDepartment of Cell and Developmental Biology, Weill Cornell Graduate School, New York, NY, USA.
Nagavarakishore PillarsettyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-1750-7436
Vladimir PonomarevMolecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jose M UdíasNuclear Physics Group, EMFTEL and IPARCOS, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0003-3714-764X
Jan GrimmDepartment of Pharmacology, Weill Cornell Graduate School, New York, NY, USA. grimmj@mskcc.org.ORCID 0000-0002-5282-9385
Joaquin L HerraizNuclear Physics Group, EMFTEL and IPARCOS, Complutense University of Madrid, Madrid, Spain. jlopezhe@ucm.es.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
[18F]-PU-AD epichaperome PET imaging probeRF1AG071805 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, DUNPHY, MARK P. · 2022 to 2025
$4.8M
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell TherapyR01CA204924 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PONOMAREV, VLADIMIR · 2016 to 2020
$3.5M
Smart and self-reporting clinical nano carriers for drug deliveryR01CA215700 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI GRIMM, JAN · 2017 to 2021
$3.5M
Image-guided TRAIL-enhanced CAR T-cell immunotherapyR01CA220524 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PONOMAREV, VLADIMIR · 2018 to 2022
$2.9M
Multicolor PET to interrogate cancer biologyR01EB033000 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI Jan Grimm, Vladimir Ponomarev · 2023 to 2026
$2.6M
The Ivis Spectrum CT for Pre-Clinical Oncology ResearchS10OD016207 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI ZANZONICO, PAT B · 2013 to 2013
$595k
Secretable theranostic payloads to augment the efficacy of adoptive CAR-T cell therapiesR21CA250478 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PONOMAREV, VLADIMIR · 2020 to 2020
$455k
Understanding tumorigenesis and metastasis of pancreatic cancer through precision whole-body imaging of senescence with ImmunoPETF32CA268912 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PRATT, EDWIN CHARLES · 2022 to 2023
$142k
NCI NIH HHS F32 CA268912NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA204924NCI NIH HHS R01 CA215700NCI NIH HHS R01 CA220524NCI NIH HHS R21 CA250478NIA NIH HHS RF1 AG071805NIBIB NIH HHS R01 EB033000NIH HHS S10 OD016207
6 · The paper itself

Abstract

In conventional positron emission tomography (PET), only one radiotracer can be imaged at a time, because all PET isotopes produce the same two 511 keV annihilation photons. Here we describe an image reconstruction method for the simultaneous in vivo imaging of two PET tracers and thereby the independent quantification of two molecular signals. This method of multiplexed PET imaging leverages the 350-700 keV range to maximize the capture of 511 keV annihilation photons and prompt γ-ray emission in the same energy window, hence eliminating the need for energy discrimination during reconstruction or for signal separation beforehand. We used multiplexed PET to track, in mice with subcutaneous tumours, the biodistributions of intravenously injected [

Indexed as

ElectronsPositron-Emission TomographyAnimalsIodine RadioisotopesMaleMiceTomography, X-Ray ComputedIodine-124Iodine Radioisotopes

Identifiers

PMID37400715
PMCPMC10810307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.